Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD)
C E Morrison1, J C Borod, M F Brin
1Comprehensive Epilepsy, New York University Medical Center, New York, NY 10016, USA. c.morrison@med.nyu.edu
Abstract:
Although improved cognition has been reported in patients with mild Parkinson's disease (PD) following the administration of levodopa, mixed results have been found in moderately-to-severely affected PD patients (MSPD), particularly in studies conducted since 1980. In the present study, 16 MSPD patients were tested on separate days, once following overnight levodopa withdrawal and once while optimally treated. A battery of neuropsychological tests that assess a range of cognitive functions (i.e., attention, language, visuospatial, memory, and executive), as well as a measure of depression, were used. Although patients performed better on a measure of confrontation naming in the untreated than in the treated condition, there were no significant differences for any of the other cognitive variables or for the depression scale variable. Thus, these data suggest that there are generally no adverse or beneficial effects of levodopa therapy on cognition in MSPD patients.
Insights
Levodopa therapy generally shows no significant cognitive benefits or detriments in moderately-to-severely affected Parkinson's disease (PD) patients. Neuropsychological testing revealed no consistent changes in attention, memory, or executive functions with PD medication.
Area of Science:
- Neuroscience
- Neurology
- Cognitive Science
Background:
- Levodopa is a primary treatment for Parkinson's disease (PD), with reported cognitive benefits in early stages.
- Cognitive effects of levodopa in moderately-to-severely affected PD patients (MSPD) remain inconsistent since 1980.
- Understanding levodopa's impact on cognition in MSPD is crucial for optimizing patient care.
Purpose of the Study:
- To investigate the effects of levodopa treatment on cognitive functions in MSPD patients.
- To assess whether optimal levodopa treatment influences attention, language, visuospatial skills, memory, and executive functions.
- To evaluate the impact of levodopa on depression symptoms in MSPD.
Main Methods:
- A cohort of 16 MSPD patients participated in the study.
- Patients underwent neuropsychological testing under two conditions: overnight levodopa withdrawal and optimal levodopa treatment.
- Cognitive functions assessed included attention, language, visuospatial abilities, memory, and executive functions, alongside a depression measure.
Main Results:
- Patients demonstrated improved performance on confrontation naming tasks when not on levodopa compared to when optimally treated.
- No statistically significant differences were observed in other cognitive domains (attention, visuospatial, memory, executive functions) between the two conditions.
- Levodopa treatment did not significantly affect the depression scale scores in MSPD patients.
Conclusions:
- Levodopa therapy does not appear to confer significant cognitive benefits for MSPD patients.
- The findings suggest that levodopa generally has neither adverse nor beneficial effects on the cognitive profile of MSPD patients.
- Further research may be needed to explore nuanced effects or alternative interventions for cognitive deficits in advanced PD.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
01:15Parkinson's Disease: Overview
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
01:24Parkinson Disease ll: Pathophysiology
01:11Alterations in Muscle Tone lll